Osprey BONK Trust provides trust services. The company is headquartered in Fairfield, Connecticut. The company went IPO on 2025-09-25. The investment objective of the Trust is solely for the shares to realize long-term capital appreciation by tracking the price of BONK tokens, non-native tokens that are compatible with the Solana Network, on each business day, less liabilities and expenses of the Trust. Osprey Funds, LLC acts as the sponsor of the Trust.
Co-Diagnostics Inc 주요 수익원은 Diagnostics Technologies이며, 최신 수익 발표에서 수익은 3,915,160입니다. 지역별로는 United States이 Co-Diagnostics Inc의 주요 시장이며, 수익은 3,523,324입니다.
Osprey Bonk Trust은 수익성이 있나요?
no, 최신 재무제표에 따르면 Co-Diagnostics Inc의 순손실은 $-37입니다.